Phase I study of dasatinib (BMS-354825) in Japanese patients with solid tumors.
Takahashi S; Miyazaki M; Okamoto I; Ito Y; Ueda K; Seriu T; Nakagawa K; Hatake K; Cancer Science, 2011, vol. 102, issue 11, p 2058, ISSN 13497006. ISBN 13497006.
Full Text Resources Located for this Citation